|
1
|
Zhao D, Liu J, Wang M, Zhang X and Zhou M:
Epidemiology of cardiovascular disease in China: current features
and implications. Nat Rev Cardiol. 16:203–212. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bauersachs R, Zeymer U, Brière JB, Marre
C, Bowrin K and Huelsebeck M: Burden of coronary artery disease and
peripheral artery disease: A literature review. Cardiovasc Ther.
2019(8295054)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Heusch G: Myocardial ischaemia-reperfusion
injury and cardioprotection in perspective. Nat Rev Cardiol.
17:773–789. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sun W, Wang Z, Sun M, Huang W and Wang Y
and Wang Y: Aloin antagonizes stimulated
ischemia/reperfusion-induced damage and inflammatory response in
cardiomyocytes by activating the Nrf2/HO-1 defense pathway. Cell
Tissue Res. 384:735–744. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Meng X, Zhang L, Han B and Zhang Z: PHLDA3
inhibition protects against myocardial ischemia/reperfusion injury
by alleviating oxidative stress and inflammatory response via the
Akt/Nrf2 axis. Environ Toxicol. 36:2266–2277. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng
YL, Cheng PW, Li CY and Li CJ: Current mechanistic concepts in
ischemia and reperfusion injury. Cell Physiol Biochem.
46:1650–1667. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xiang M, Lu Y, Xin L, Gao J, Shang C,
Jiang Z, Lin H, Fang X, Qu Y, Wang Y, et al: Role of oxidative
stress in reperfusion following myocardial ischemia and its
treatments. Oxid Med Cell Longev. 2021(6614009)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Abouzaki NA, Christopher S, Trankle C, Van
Tassell BW, Carbone S, Mauro AG, Buckley L, Toldo S and Abbate A:
Inhibiting the inflammatory injury after myocardial ischemia
reperfusion with plasma-derived Alpha-1 Antitrypsin: A post hoc
analysis of the VCU-α1RT study. J Cardiovasc Pharmacol. 71:375–379.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Heusch G: Molecular basis of
cardioprotection: Signal transduction in ischemic pre-, post-, and
remote conditioning. Circ Res. 116:674–699. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shi ZY, Zeng JZ and Wong AST: Chemical
structures and pharmacological profiles of ginseng saponins.
Molecules. 24(2443)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kim JH, Yi YS, Kim MY and Cho JY: Role of
ginsenosides, the main active components of Panax ginseng, in
inflammatory responses and diseases. J Ginseng Res. 41:435–443.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hsieh YH, Deng JS, Chang YS and Huang GJ:
Ginsenoside Rh2 ameliorates lipopolysaccharide-induced acute lung
injury by regulating the TLR4/PI3K/Akt/mTOR, Raf-1/MEK/ERK, and
Keap1/Nrf2/HO-1 signaling pathways in mice. Nutrients.
10(1208)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ma R, Tian JH, Jiang J and Jin X:
Inhibitory activities of ginsenosides on the activation of NLRP3
inflammasome. J China Pharm Univ. 47:614–618. 2016.
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tian Y, Deng P, Li B, Wang J, Li J, Huang
Y and Zheng Y: Treatment models of cardiac rehabilitation in
patients with coronary heart disease and related factors affecting
patient compliance. Rev Cardiovasc Med. 20:27–33. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kakavand H, Aghakouchakzadeh M, Coons JC
and Talasaz AH: Pharmacologic prevention of myocardial
ischemia-reperfusion injury in patients with acute coronary
syndrome undergoing percutaneous coronary intervention. J
Cardiovasc Pharmacol. 77:430–449. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Im DS: Pro-resolving effect of
ginsenosides as an anti-inflammatory mechanism of panax ginseng.
Biomolecules. 10(444)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li L, Wang Y, Guo R, Li S, Ni J, Gao S,
Gao X, Mao J, Zhu Y, Wu P, et al: Ginsenoside Rg3-loaded, reactive
oxygen species-responsive polymeric nanoparticles for alleviating
myocardial ischemia-reperfusion injury. J Control Release.
317:259–272. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xu X, Jin L, Jiang T, Lu Y, Aosai F, Piao
HN, Xu GH, Jin CH, Jin XJ, Ma J and Piao LX: Ginsenoside Rh2
attenuates microglial activation against toxoplasmic encephalitis
via TLR4/NF-κB signaling pathway. J Ginseng Res. 44:704–716.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shi X, Tao G, Ji L and Tian G: Sappanone a
protects against myocardial ischemia reperfusion injury by
modulation of Nrf2. Drug Des Devel Ther. 14:61–71. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shen Y, Liu X, Shi J and Wu X: Involvement
of Nrf2 in myocardial ischemia and reperfusion injury. Int J Biol
Macromol. 125:496–502. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cheng Y, Cheng L, Gao X, Chen S, Wu P,
Wang C and Liu Z: Covalent modification of Keap1 at Cys77 and
Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3
inflammasome activation in myocardial ischemia-reperfusion injury.
Theranostics. 11:861–877. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Huang CY, Deng JS, Huang WC, Jiang WP and
Huang GJ: Attenuation of lipopolysaccharide-induced acute lung
injury by hispolon in mice, through regulating the
TLR4/PI3K/Akt/mTOR and Keap1/Nrf2/HO-1 pathways, and suppressing
oxidative stress-mediated er stress-induced apoptosis and
autophagy. Nutrients. 12(1742)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang CJ and Yang J, Fan ZX and Yang J:
Activating transcription factor 3-an endogenous inhibitor of
myocardial ischemia-reperfusion injury (Review). Mol Med Rep.
13:9–12. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tschopp J, Martinon F and Burns K: .
NALPs: A novel protein family involved in inflammation. Nat Rev Mol
Cell Biol. 4:95–104. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Irrera N, Russo M, Pallio G, Bitto A,
Mannino F, Minutoli L, Altavilla D and Squadrito F: The role of
NLRP3 inflammasome in the pathogenesis of traumatic brain injury.
Int J Mol Sci. 21(6204)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kelley N, Jeltema D, Duan Y and He Y: The
NLRP3 inflammasome: An overview of mechanisms of activation and
regulation. Int J Mol Sci. 20(3328)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jun JH, Shim JK, Oh JE, Shin EJ, Shin E
and Kwak YL: Protective effect of ethyl pyruvate against myocardial
ischemia reperfusion injury through regulations of ros-related
NLRP3 inflammasome activation. Oxid Med Cell Longev.
2019(4264580)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Shen S, He F, Cheng C, Xu B and Sheng J:
Uric acid aggravates myocardial ischemia-reperfusion injury via
ROS/NLRP3 pyroptosis pathway. Biomed Pharmacother.
133(110990)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang
S, Deng X, Xie Z and Zheng S: Isoliquiritigenin alleviates early
brain injury after experimental intracerebral hemorrhage via
suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome
activation by promoting Nrf2 antioxidant pathway. J
Neuroinflammation. 14(119)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang F, Wang H, Liu X, Yu H, Huang X,
Huang W and Wang G: Neuregulin-1 alleviate oxidative stress and
mitigate inflammation by suppressing NOX4 and NLRP3/caspase-1 in
myocardial ischaemia-reperfusion injury. J Cell Mol Med.
25:1783–1795. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang DS, Yan LY, Yang DZ, Lyu Y, Fang LH,
Wang SB and Du GH: Formononetin ameliorates myocardial
ischemia/reperfusion injury in rats by suppressing the
ROS-TXNIP-NLRP3 pathway. Biochem Biophys Res Commun. 525:759–766.
2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang Y, Hu Z, Sun B, Xu J, Jiang J and Luo
M: Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion
injury via Akt/endothelial nitric oxide synthase signaling and the
B-cell lymphoma/B-cell lymphoma-associated X protein pathway. Mol
Med Rep. 11:4518–4524. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zeng X, Li J and Li Z: Ginsenoside Rd
mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1
signaling pathway. Int. J Clin Exp Med. 8:14497–14504.
2015.PubMed/NCBI
|
|
35
|
Qin GW, Lu P, Peng L and Jiang W:
Ginsenoside rb1 inhibits cardiomyocyte autophagy via pi3k/akt/mtor
signaling pathway and reduces myocardial ischemia/reperfusion
injury. Am J Chin Med. 49:1913–1927. 2021.PubMed/NCBI View Article : Google Scholar
|
